Post-Deployment Polypharmacy and Opioid Receipt Among Active Duty Soldiers Returning from Afghanistan and Iraq: A Retrospective Study
This study extends the knowledge base on HRM among AD soldiers by analyzing longitudinal data over an expanded timeframe, considering additional definitions, and examining patterns of overlap among types of HRM. The high prevalence of first-year and post-deployment AD career HRM and the average time to HRM receipt suggest that the first 2 years following deployment may be a critical period for HRM monitoring. Given that over half of AD Army soldiers received HRM in their post-deployment career period, findings underscore the value of Defense Health Agency post-deployment medication monitoring initiatives.
Authors
- Rachel Sayko Adams (ORCID: https://orcid.org/0000-0003-4450-0712)
- Nick Huntington (ORCID: https://orcid.org/0000-0002-2341-6100)
- Ryan C. Costantino (ORCID: https://orcid.org/0000-0003-4554-3802)
- Mary Jo Larson (ORCID: https://orcid.org/0000-0003-3417-2882)
- Natalie Moresco (ORCID: https://orcid.org/0000-0002-2468-6292)
- Krista B. Highland (ORCID: https://orcid.org/0000-0003-3815-2571)
- Jenneth Carpenter
- Mark R. Bauer (ORCID: https://orcid.org/0000-0001-6221-2197)
Institutions
- Boston University (US)
- United States Department of the Army (US)
- Uniformed Services University of the Health Sciences (US)
- Brandeis University (US)
Publication Details
- Journal
- Military Medicine
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1093/milmed/usaf496
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00